Poster Blasts

Programm

• • Flash Talk

  Additional Immunovirotherapy of NUT Carcinoma with the Oncolytic Herpes Simplex Virus T-VEC and the Immune Checkpoint Inhibitor Pembrolizumab

  • Linus Kloker (Tübingen / DE)

   Cancer immunotherapies
• • Flash Talk

  Making the effect visible – Nanobodies for in vivo imaging of activated T cells

  • Desiree I. Frecot (Reutlingen / DE)

   Cancer immunotherapies
• • Flash Talk

  The microbiome as a checkpoint blockade therapy adjuvant

  • Lukas Mager (Tübingen / DE)

   Cancer immunotherapies
• • Flash Talk

  Prospective phase I/II trial of an individualized peptide vaccine in pediatric and AYA patients with metastasized fusion-driven sarcomas following standard treatment – PerVision

  • Christian M. Seitz (Tübingen / DE)

   Cancer immunotherapies
• • Flash Talk

  Systematic Side-by-Side Comparison of [¹⁸F]Olaparib and [¹⁸F]Talazoparib as PARP Imaging Agents in an HR-Deficient Breast Cancer Xenograft Model

  • Sophie Stotz (Tübingen / DE)

   Functional and molecular multiparametric imaging of cancer
• • Flash Talk

  Clinical application of [¹⁸F]FPyGal: the detection of in vivo senescence

  • Jonathan Cotton (Tübingen / DE)

   Functional and molecular multiparametric imaging of cancer
• • Flash Talk

  Immunological Profiling of Cancer by automated Ultra-High Content Imaging

  • Sophia Scheuermann (Tübingen / DE)

   Functional and molecular multiparametric imaging of cancer
• • Flash Talk

  1st in class small molecule inhibitors of MKK4 to overcome resistance towards KRASG12C or MEK inhibitors in Non-small cell lung cancer

  • Moritz Schmidt (Tübingen / DE)

   Functional target discovery, preclinical models and new drugs in oncology
• • Flash Talk

  Development and characterization of kinase sparing TPX2-tethering Aurora Kinase A ligands for the therapy of cancer

  • Athina Anastasia Moschopoulou (Tübingen / DE)

   Functional target discovery, preclinical models and new drugs in oncology
• • Flash Talk

  Exploiting LXRalpha activation for lipotoxic cancer therapies

  • Pascal Wölffing (Tübingen / DE)

   Functional target discovery, preclinical models and new drugs in oncology
• • Flash Talk

  An optimized system for genome-scale CRISPR screens identifies in vivo dependencies in pancreatic cancer

  • Vivien Vogt (Vienna / AT)

   Functional target discovery, preclinical models and new drugs in oncology
• • Flash Talk

  A novel CRISPR/Cas9 knockout library uncovers pan-essential miRNAs in human cancer cell lines

  • Daniel J. Merk (Tübingen / DE)

   Functional target discovery, preclinical models and new drugs in oncology
• • Flash Talk

  Co-transcriptional splicing is a vulnerability of Ras-driven cells

  • Verena Wagner (Tübingen / DE)

   Functional target discovery, preclinical models and new drugs in oncology